Daytime Sleepiness, Driving Performance, Reaction Time and Inhibitory Control during Sleep Restriction Therapy for Chronic Insomnia Disorder

Publication date: Available online 2 November 2017
Source:Sleep Medicine
Author(s): Hannah Whittall, Meg Pillion, Michael Gradisar
BackgroundSleep restriction therapy (SRT) is a largely untested single treatment component of cognitive-behaviour therapy for insomnia. To date, the evidence for contraindications for SRT is limited to very few studies. The present study investigated the objective and subjective daytime consequences during the acute phase of SRT for adults diagnosed Chronic Insomnia Disorder.MethodsSixteen adults (age=36.3±13.4 yrs, 12 females, 4 males) underwent SRT for their insomnia over a 2-week period based on recommendations by Miller and colleagues (2014)⁶. Participants completed sleep diaries, self-reported daytime sleepiness (Epworth Sleepiness Scale [ESS]), as well as objective measures of reaction time/inhibition (Go/NoGo task) and driving performance (AusEd driving simulator) at pre-, mid- (i.e., after 1 week of SRT) and post-SRT (after 2 weeks of SRT).ResultsSleep diary outcomes indicated participants complied with the restriction of time in bed, and that a similar amount of total sleep time (TST) was maintained from pre-to-post-treatment. There was no significant change in daytime sleepiness, and similarly no significant changes observed in objective performance on the Go/NoGo task and AusEd driving simulator.ConclusionsThese preliminary results suggest SRT during the acute phase does not appear to place insomnia patients at risk of significant impairments in sleepiness and reaction times. We note these findings can only be translated into clinical practice when sleep duration remains relatively unchanged. Future studies using objective measures of sleep and a control group are recommended.



from A via xlomafota.13 on Inoreader http://ift.tt/2lEX4Ne
via IFTTT